Expert Review of Neurotherapeutics

Article	Citations
Does electrical stimulation still have a place in the treatment armamentarium for Bell’s palsy?	43
How have the recent updated epilepsy classifications impacted on diagnosis and treatment?	36
Ultrasensitive techniques and protein misfolding amplification assays for biomarker-guided reconceptualization of Alzheimer’s and other neurodegenerative diseases	33
Where Art Thou O treatment for diabetic neuropathy: the sequel	32
The role of Fecal Microbiota Transplantation (FMT) in treating patients with multiple sclerosis	31
Neonatal seizures treatment based on conventional multichannel EEG monitoring: an overview of therapeutic options	28
Outcomes measures in idiopathic intracranial hypertension	27
Profiling deutetrabenazine extended-release tablets for tardive dyskinesia and chorea associated with Huntington’s disease	27
An overview of the differences in the pharmacological management of post-traumatic stress disorder between women and men	26
Determining minimally clinically important differences for outcome measures in patients with chronic motor deficits secondary to traumatic brain injury	26
Advances in the treatment and management of frontotemporal dementia	25
Laser interstitial thermal therapy for recurrent brain metastases following stereotactic radiosurgery: a systematic review	23
The relevance of cortical thickness in migraine sufferers and implications to therapy	23
Immunomodulatory effects and clinical benefits of intravenous immunoglobulin in myasthenia gravis	23
The influence of anxiety and depression on headache in adolescent migraineurs: a case-control study	22
The current status of somatostatin analogs in the treatment of neuroendocrine tumors and future perspectives	21
Why is ADHD so difficult to diagnose in older adults?	21
The latest developments with internet-based psychological treatments for depression	21
Emerging role of artificial intelligence in stroke imaging	20
Managing antipsychotic-related sexual dysfunction in patients with schizophrenia	19
Updated review on the link between cortical spreading depression and headache disorders	19
Post Intensive Care Syndrome (PICS): an overview of the definition, etiology, risk factors, and possible counseling and treatment strategies	19
Recent advancements in tension-type headache: a narrative review	19
Viloxazine extended-release capsules as an emerging treatment for attention-deficit/hyperactivity disorder in children and adolescents	19
Acute and long-term cognitive impairment following sepsis: mechanism and prevention	18

Correction	18
Hesitancies in primary headaches treatments	18
Diagnosing epileptic seizures in patients with Alzheimer’s disease and deciding on the appropriate treatment plan	17
Treating subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: an update of the literature	17
An overview of ganaxolone as a treatment for seizures associated with cyclin-dependent kinase-like 5 deficiency disorder	17
Advances in the early diagnosis of amyotrophic lateral sclerosis	17
An update on the pharmacological management of Tourette syndrome and emerging treatment paradigms	17
Spinal automaticity of movement control and its role in recovering function after spinal injury	17
Current and emerging diagnostic and management approaches for idiopathic intracranial hypertension	17
Food for thought: the emerging role of a ketogenic diet in Alzheimer’s disease management	16
Mindfulness as a therapeutic option for obsessive-compulsive disorder	16
Advances in gene therapy for high-grade glioma: a review of the clinical evidence	15
Comparison of the retention rate, safety, and efficacy of two different titration protocols for lamotrigine in newly diagnosed epilepsy patients	15
Current use of neurotoxins for alleviating symptoms of cervical dystonia	15
Current perspectives on the diagnosis, assessment, and management of vasculitic neuropathy	14
Essential Tremor – Deep Brain Stimulation vs. Focused Ultrasound	14
Efficacy and safety of vigabatrin in patients with tuberous sclerosis complex and infantile epileptic spasm syndrome: a systematic review	14
The differential diagnosis of autism spectrum disorder in adults	14
Illuminating the way: the role of bright light therapy in the treatment of depression	14
Virtual reality technology in the treatment of anxiety – progress and future challenges	13
Evaluating the value and risks of psychedelics for psychiatric medicine: a clinical perspective	13
Revisiting stimulant use for emotional dysregulation in attention-deficit/hyperactivity disorder (ADHD)	13
Considerations for hormonal therapy in migraine patients: a critical review of current practice	13
Frontotemporal dementia. How to deal with its diagnostic complexity?	13
Distinguishing essential tremor from Parkinson’s disease: clinical and experimental tools	13
Cross-national reflections on medicinal cannabis and depression	13
A novel treatment option for intrajejunal levodopa administration	13
Psychotherapeutic treatments for generalized anxiety disorder: cognitive and behavioral therapies, enhancement strategies, and emerging efforts	12
Trends in disease-modifying therapy use in patients with multiple sclerosis using a 10-year population-based cohort study in France	12
Long-term outcomes in refractory status epilepticus	12
Advancements in neuroactive peptides in seizures	12
Considering hearing loss as a modifiable risk factor for dementia	12
Updated review of rescue treatments for seizure clusters and prolonged seizures	11
Using oral topiramate for primary generalized and focal-to-bilateral tonic-clonic seizures in patients 2 years of age and older: a review of the literature	11
The effectiveness of electroconvulsive therapy (ECT) for people with bipolar disorder: is there a specific role?	11
An updated review on the role of prescribed exercise in the management of Amyotrophic lateral sclerosis	11
Developments in the prediction of cognitive changes following deep brain stimulation in persons with Parkinson’s disease	11
Pathogenesis, diagnosis and treatment of paraneoplastic neurologic syndromes	11
A critical review of incobotulinumtoxinA in the treatment of chronic sialorrhea in pediatric patients	11
Retinal optical coherence tomography and magnetic resonance imaging in neuromyelitis optica spectrum disorders and MOG-antibody associated disorders: an updated review	11
Profiling aducanumab as a treatment option for Alzheimer’s disease: an overview of efficacy, safety and tolerability	10
Combinations of dextromethorphan for the treatment of mood disorders - a review of the evidence	10
Radiosurgical thalamotomy for essential tremor: state of the art, current challenges and future directions	10
Teriflunomide: an oral therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis	10
Current perspectives on the recognition and diagnosis of low CSF pressure headache syndromes	10
Imaging protocols for non-traumatic spinal cord injury: current state of the art and future directions	10
Bipolar disorder staging and the impact it has on its management: an update	10
Efficacy analysis of three brain stimulation techniques for Alzheimer’s disease: a meta-analysis of repeated transcranial magnetic stimulation, transcranial direct current stimulation, and deep brain	10
Managing impulse control and related behavioral disorders in Parkinson’s disease: where we are in 2025?	10
Therapeutic issues in Guillain–Barré syndrome	10

Why lithium should be used in patients with bipolar disorder? A scoping review and an expert opinion paper	10
An update on the role of magnetic resonance imaging in predicting and monitoring multiple sclerosis progression	10
Family accommodation: a diagnostic feature of obsessive-compulsive disorder?	10
Long-term central nervous system (CNS) consequences of COVID-19 in children	9
Neuromodulation as a treatment strategy in Lennox-Gastaut syndrome: evidence and future directions	9
Cognitive or daily stress association with headache and pain induction in migraine and tension-type headache patients: a systematic review	9
A review of a diazepam nasal spray for the treatment of acute seizure clusters and prolonged seizures	9
Rethinking the role of trazodone in the different depressive dimensions	9
Pharmacotherapy of schizophrenia: immunological aspects and potential role of immunotherapy	9
Developments in targeting calcitonin gene-related peptide	9
Meniere disease subtyping: the direction of diagnosis and treatment in the future	9
Imaging of infectious and inflammatory cystic lesions of the brain, a narrative review	9
Pharmacological and non-pharmacological treatment options for sleep disturbances in Alzheimer’s disease	8
Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions	8
What are the main challenges in the treatment of neonatal hypoxic ischemic encephalopathy?	8
Combination of noninvasive brain stimulation and constraint-induced movement therapy in patients with stroke: a systematic review and meta-analysis	8
An update on pharmacotherapy for trigeminal neuralgia	8
Deep brain stimulation: new programming algorithms and teleprogramming	8
Updated review of therapeutic strategies for Charcot-Marie-Tooth disease and related neuropathies	8
Omaveloxolone for the treatment of Friedreich ataxia: clinical trial results and practical considerations	8
Ublituximab-xiiy as a treatment option for relapsing multiple sclerosis	8
The major challenges with pharmacologic management of chronic traumatic encephalopathy	8
Risk of suicide and suicide-related events in subjects treated with antiseizure medications	8
What is the potential of paramagnetic rim lesions as diagnostic indicators in multiple sclerosis?	8
The benefits and risks of escalation versus early highly effective treatment in patients with multiple sclerosis	8
Learnings in developmental and epileptic encephalopathies: what do we know?	8
Superior treatment efficacy of neuromodulation rehabilitation for upper limb recovery after stroke: a meta-analysis	8
Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson’s disease	8
A critical review of fosphenytoin sodium injection for the treatment of status epilepticus in adults and children	7
Olanzapine-samidorphan combination tablets for the treatment of schizophrenia and bipolar I disorder - what is it, and will it be used?	7
Re-evaluating the prognosis of schizophrenia: tackling the issue of inadequate treatment	7
An update on clinical insight, cognitive insight, and introspective accuracy in schizophrenia-spectrum disorders: symptoms, cognition, and treatment	7
The challenges and opportunities related to the therapeutic use of music in psychiatry	7
Sydenham’s chorea: from pathophysiology to therapeutics	7
The complexities in the differential diagnosis of restless legs syndrome (Willis–Ekbom disease)	7
Adaptive, personalized closed-loop therapy for Parkinson’s disease: biochemical, neurophysiological, and wearable sensing systems	7
Insulin signaling in the central nervous system, a possible pathophysiological mechanism of anesthesia-induced delayed neurocognitive recovery/postoperative neurocognitive disorder: a narrative review	7
Gene therapy for Duchenne muscular dystrophy: an update on the latest clinical developments	7
Contemporary diagnosis and treatment of conduct disorder in youth	7
Current perspectives on the benefits, risks, and limitations of noninvasive brain stimulation (NIBS) for post-stroke dysphagia	7
Letter to the editor: reflections on the future of medical cannabis research for depression	6
Switching between anti-CGRP monoclonal antibodies in migraine prophylaxis	6
A proposal for a shared therapeutic algorithm in children with prolonged convulsive seizures and status epilepticus	6
What impact can brain stimulation interventions have on borderline personality disorder?	6
Relationship between anti-seizure medication and behaviors that challenge in older persons with intellectual disability and epilepsy: a review	6
Current and emerging therapies for autoimmune encephalitis	6
The burden of migraine in Mexico: a database analysis of migraine-related visits to emergency departments in Mexico’s Ministry of Health (MMoH) hospitals	6
Viloxazine extended-release capsules for the treatment of attention-deficit/ hyperactivity disorder in adult patients	6
Updated perspectives on how and when lithium should be used in the treatment of mood disorders	6
The changing landscape of neuroimaging in frontotemporal lobar degeneration: from group-level observations to single-subject data interpretation	6
Pharmacological approaches to the management of panic disorder in older patients: a systematic review	6
Pharmacotherapy and cognitive bias modification for the treatment of anxiety disorders	6
Advances in stem cell-based therapeutic transfers for glioblastoma treatment	6
Exploring the role of botulinum toxin in critical care	6
Obtaining long-term recovery: advances in optimizing treatment outcomes in patients with binge-eating disorder	6
Effects of spinal stabilization exercises delivered using telerehabilitation on outcomes in patients with chronic neck pain: a randomized controlled trial	5
Is postpartum depression a clinically useful concept?	5
Tele-healthcare in migraine medicine: from diagnosis to monitoring treatment outcomes	5
Insights into headache 2022	5
Advances in the systemic therapy for recurrent meningiomas and the challenges ahead	5
Considerations for the treatment of obsessive-compulsive disorder in patients who have comorbid major depression	5
The APOE ε4 variant and hippocampal atrophy in Alzheimer’s disease and Lewy body dementia: a systematic review of magnetic resonance imaging studies and therapeutic relevance	5
Emerging antibody-based therapies for Huntington’s disease: current status and perspectives for future development	5
Is it possible to prevent relapse in panic disorder?	5
Sublingual dexmedetomidine: repurposing an anesthetic as an anti-agitation agent	5
Pharmacological options for narcolepsy: are they the way forward?	5
Telerehabilitation in neurorehabilitation: has it passed the COVID test?	5
Therapeutic plasma exchange with albumin: a new approach to treat Alzheimer’s disease	5
Assessment of clinical outcomes of medicinal cannabis therapy for depression: analysis from the UK Medical Cannabis Registry	5
Safety and tolerability of nabiximols oromucosal spray: a review of more than 15 years” accumulated evidence from clinical trials	5
When is pharmacological intervention recommended for adults with social anxiety disorder?	5
Neuromodulation as a therapeutic approach for post-traumatic stress disorder: the evidence to date	5
Central vestibular dysfunction: don’t forget vestibular rehabilitation	5
Imaging of congenital and developmental cystic lesions of the brain: a narrative review	5
Challenges in the treatment of dysthymia: a narrative review	5
Expert guidance on the differential diagnosis of neuroleptic malignant syndrome	5
Headache as a COVID-19 onset symptom or Post-COVID symptom according to the SARS-CoV-2 Variant	4
The advances in the early and accurate diagnosis of Creutzfeldt–Jakob disease and other prion diseases: where are we today?	4
Postoperative pain: a review of emerging therapeutic options	4
Therapeutic barriers for headache management: issues facing the global north and global south in 2024	4

What is the role of placebo in neurotherapeutics?	4
Pain in cervical dystonia: mechanisms, assessment and treatment	4
Correlation between systemic bleeding during thrombolysis and intracranial hemorrhage after thrombolysis in acute ischemic stroke	4
Current and emerging pharmaceutical strategies for the treatment and management of restless legs syndrome	4
Rimegepant for the acute and preventive treatment of migraine: a narrative review of the evidence	4
Current perspectives on the diagnosis and management of acute transverse myelitis	4
Novel and emerging therapeutics for genetic epilepsies	4
Fifty years of experience with loxapine for the rapid non-coercive tranquilization of acute behavioral disturbances in schizophrenia patients, and beyond	4
Is there a therapeutic potential in combining bupropion and naltrexone in schizophrenia?	4
Clinical considerations for rapid administration of undiluted or minimally diluted levetiracetam bolus doses	4
The promise and challenges of transcranial magnetic stimulation and deep brain stimulation as therapeutic options for obsessive-compulsive disorder	4
Can regular physical exercise be a treatment for panic disorder? A systematic review	4
Menopause and its impact on the effectiveness of fremanezumab for migraine prophylaxis: post-hoc analysis of a prospective, real-world Greek registry	4
Brain atrophy assessment in multiple sclerosis: technical– and subject-related barriers for translation to real-world application in individual subjects	4
How could brain fingerprinting lead to the early detection of mental illness in adolescents and what are the next steps?	4
Rethinking the medication management of major depression	4
A review of amphetamine extended release once-daily options for the management of attention-deficit hyperactivity disorder	4
Why does exposure-based therapy fail in some individuals with obsessive-compulsive disorder?	4
Therapeutic plasma exchange for myasthenia gravis, Guillain-Barre syndrome, and other immune-mediated neurological diseases, over a 40-year experience	4
UK Medical Cannabis Registry: a cohort study of patients prescribed cannabis-based oils and dried flower for generalised anxiety disorder	4
How does “Pure-O” obsessive-compulsive disorder impact on a patient’s treatment plan?	4
Adapting psychedelic medicine for headache and chronic pain disorders	4
Accelerating the development of noninvasive brain stimulation devices: using design thinking to facilitate its clinical use and acceptance	4
The impact of cognitive reserve relative to risk of Alzheimer’s disease and rate of progression: an up-to-date review of the literature	4
An overview of the efficacy and safety of brexpiprazole for the treatment of schizophrenia in adolescents	4
Developments in the assessment of non-motor disease progression in amyotrophic lateral sclerosis	3
Therapeutic strategies that modulate the acute phase of secondary spinal cord injury scarring and inflammation and improve injury outcomes	3
The management of neurofibromatosis type 1 (NF1) in children and adolescents	3
Stereotaxic-assisted gene therapy in Alzheimer’s and Parkinson’s diseases: therapeutic potentials and clinical frontiers	3
Emerging frontiers in Chronic Traumatic Encephalopathy: early diagnosis and implications for neurotherapeutic interventions	3
The utility of magnetoencephalography in epilepsy and its implications for treatment	3
Can pharmacotherapy help to reduce trichotillomania?	3
Nanomaterials in neuromodulation: what is the potential?	3
Overcoming barriers to the management of seizure clusters: ease of use and time to administration of rescue medications	3
Alpha-synuclein in Parkinson's disease: a villain or tragic hero? A critical view of the formation of α-synuclein aggregates induced by dopamine metabolites and viral infection	3
Transcranial direct-current stimulation of the prefrontal cortex enhances working memory and suppresses pathological gamma power elevation in schizophrenia	3
Current and emerging treatment options for Angelman syndrome	3
Real world considerations for newly approved CGRP receptor antagonists in migraine care	3
Withdrawal of antiseizure medications – for whom, when, and how?	3
Outcome measures and biomarkers in chronic inflammatory demyelinating polyradiculoneuropathy: from research to clinical practice	3
How should future clinical trials be designed in the search for disease-modifying therapies for Parkinson’s disease?	3
Careful considerations for the treatment of posttraumatic stress disorder during and following pregnancy	3
The human functional connectome in neurodegenerative diseases: relationship to pathology and clinical progression	3
Evaluating fenfluramine hydrochloride as an oral solution for the treatment of seizures associated with Lennox-Gastaut syndrome	3
Overcoming clinical challenges of refractory neuropathic pain	3
Emerging biomarkers to predict clinical outcomes in Guillain–Barré syndrome	3
A systematic review of European regional and national guidelines: a focus on the recommended use of nabiximols in the management of spasticity in multiple sclerosis	3
Essential tremor - drug treatments present and future	3
Guidance on antipsychotic selection for agitation and aggressive behavior in persons with Huntington’s disease	3
An overview of the utility of prasugrel hydrochloride as a treatment option for ischemic stroke	3
Are ketamine and its enantiomers the answer to treatment-refractory depression?	3
Risk factors and disease associations in people living with idiopathic intracranial hypertension	3
Tumefactive demyelination: updated perspectives on diagnosis and management	3